Clik here to view.
MassDevice.com +5 | The top 5 medtech stories for February 24, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
7 disruptive innovations from medical device suppliers
Sometimes an innovation out of a contract manufacturer is truly disruptive when it comes to its potential for the medical device industry. Chris Newmarker, Managing Editor [Image from Unsplash.]People...
View ArticleClik here to view.
Study: Abbott’s CardioMEMS monitor performs better in real world than pivotal...
Real-world results from patients with Abbott‘s (NYSE:ABT) CardioMEMS implantable heart monitor, which it acquired along with St Jude Medical in Jan., show greater reduction in pulmonary artery pressure...
View ArticleClik here to view.
Study: Shifting to radial access PCIs could save hospitals $332m a year
A new study has shown that shifting 30% of femoral-access PCI procedures to transradial-access with same-day discharge for stable patients could save U.S. hospitals $332 million annually....
View ArticleClik here to view.
Augmenix touts more SpaceOar data
Augmenix touted data today from a Phase III trial evaluating its SpaceOar hydrogel in men undergoing prostate radiotherapy. The study showed that the company’s device, placed between the prostate and...
View ArticleClik here to view.
Target is supporting health and wellness startups: Here’s how
U.S. retail giant Target is taking the initiative to support health startups around the world, with a goal of boosting its wellness product offerings. Target is launching a new program called “Target...
View ArticleClik here to view.
7 medtech stories we missed this week: Feb. 24, 2017
[Photo from unsplash.com]Several companies made distribution deals this week, while others received approval for their products. Here are 7 medtech stories we missed this week but were still worth...
View ArticleClik here to view.
TransEnterix shares dip despite 1st sale in Germany
Shares in TransEnterix (NYSE:TRXC) have dipped today despite the robotic surgical maker announcing yesterday that it landed the 1st sale of the system in Germany. The Research Triangle, N.C.-based...
View ArticleClik here to view.
Scientists test deep brain stimulation as potential anorexia therapy
(Reuters) – A small study in 16 people with severe anorexia has found that implanting stimulation electrodes into the brains of patients could ease their anxiety and help them gain weight. Researchers...
View ArticleClik here to view.
Spectranetics shares rise on Q4, FY2016 beat
Shares in Spectranetics (NSDQ:SPNC) rose today after the medical device maker beat expectations on Wall Street with its 4th quarter and fiscal year 2016 earnings report. The Colorado Springs,...
View ArticleClik here to view.
Nevro shares rise on Q4, FY2016 rev Beat
Shares in Nevro Corp. (NYSE:NVRO) rose today after the medical device maker beat revenue expectations, despite falling short in earnings per share with its 4th quarter earnings results. The Redwood...
View ArticleClik here to view.
Johnson & Johnson closes $4.3B Abbott Medical Optics buy
Johnson & Johnson (NYSE:JNJ) said today that it closed the $4.33 billion buyout of Abbott Medical Optics from Abbott (NYSE:ABT). The deal for AMO, announced in September 2016, includes its...
View ArticleClik here to view.
FDA accepts AcelRx’s NDA for Dsuvia pain reliever
AcelRx Pharmaceuticals (NSDQ:ACRX) said today that the FDA accepted the company’s New Drug Application for its Dsuvia pain relief therapy. The federal watchdog set a target decision date for October 12...
View ArticleClik here to view.
Halyard Health ticks up on Q4 sales, earnings beats
Halyard Health (NYSE:HYH) shares gained today in pre-market trading after the company reported 4th-quarter results that topped the consensus forecast on Wall Street. Alpharetta, Ga.-based Halyard, the...
View ArticleClik here to view.
OncoSec wins fast track designation for electroporation combo therapy
OncoSec Medical (NSDQ:ONCS) said today that it won Fast Track Designation from the FDA for its ImmunoPulse IL-12 electroporation gene therapy for the treatment of metastatic melanoma. The biotech...
View ArticleClik here to view.
Study: Nanotechnology could cut dose of HIV treatment in half
Researchers from the University of Liverpool presented data this week evaluating the use of nanotechnology to improve drug therapies for HIV patients. The team touted its data at the Conference on...
View ArticleClik here to view.
FDA green-lights Cagent Vascular’s Serranator Alto PAD balloon catheter
Cagent Vascular said today that it won 510(k) clearance from the FDA for its Serranator Alto balloon catheter, which is designed to treat peripheral artery disease. The Wayne, Pa.-based company bills...
View ArticleClik here to view.
Report finds pharma companies limited January list price hikes
Drug-makers didn’t raise list prices for as many drugs in January compared to last year and they initiated fewer hikes of 10% or more, according to analysis by Raymond James & Associates. Although...
View ArticleClik here to view.
Integra LifeSciences slides on Q4 sales miss
Integra LifeSciences (NSDQ:IART) met the consensus earnings forecast for its 4th-quarter earnings, but saw share prices slide nevertheless after it missed Wall Street’s top-line outlook last week. The...
View ArticleClik here to view.
Clearside bails on AMD, all-in on diabetic macular edema
Clearside Biomedical (NSDQ:CLSD) said today it will redirect its R&D efforts from its pre-clinical axitinib wet age-related macular degeneration therapy to its Zuprata diabetic macular edema...
View Article
